Stocks and Investing
Stocks and Investing
Fri, April 1, 2022
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
[ Fri, Apr 01st 2022
] - WOPRAI
Thu, March 31, 2022
[ Thu, Mar 31st 2022
] - WOPRAI
[ Thu, Mar 31st 2022
] - WOPRAI
[ Thu, Mar 31st 2022
] - WOPRAI
[ Thu, Mar 31st 2022
] - WOPRAI
[ Thu, Mar 31st 2022
] - WOPRAI
[ Thu, Mar 31st 2022
] - WOPRAI
Edward Nash Initiated (VTYX) at Strong Buy and Held Target at $30 on, Mar 31st, 2022
Edward Nash of Canaccord Genuity, Initiated "Ventyx Biosciences, Inc." (VTYX) at Strong Buy and Held Target at $30 on, Mar 31st, 2022.
Edward has made no other calls on VTYX in the last 4 months.
There is 1 other peer that has a rating on VTYX. Out of the 1 peers that are also analyzing VTYX, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Jeff Jones of "Oppenheimer" Initiated at Buy and Held Target at $30 on, Tuesday, February 1st, 2022
Contributing Sources